Search
Search Results
-
Should We “RESPECT EPA” More Now? EPA and DHA for Cardiovascular Risk Reduction
Purpose of ReviewThere has been much debate surrounding the use of omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA),...
-
A Critical Review of Icosapent Ethyl in Cardiovascular Risk Reduction
Icosapent ethyl (IPE) was the first fish oil product the US Food and Drug Administration (FDA) approved to reduce the risk of atherosclerotic...
-
Cardiovascular Risk Scales Association with Cerebrospinal Fluid Alzheimer’s Disease Biomarkers in Cardiovascular Low Cardiovascular Risk Regions
BackgroundCardiovascular risk factors are associated with Alzheimer’s Disease (AD) development. However, few studies compare the overall...
-
Cardiovascular Disease Risk Reduction and Body Mass Index
Purpose of ReviewAnti-hypertensive and lipid lowering therapy addresses only half of the cardiovascular disease risk in patients with body mass...
-
Preventive Cardiovascular Nursing Resilience across the Lifespan for Optimal Cardiovascular Wellness
This book provides a comprehensive overview of essential concepts and evidence that guide the practice of contemporary preventive cardiovascular...
-
Cardiovascular risk reduction with integrated care: results of 8 years follow up
BackgroundCare groups organize integrated cardiovascular risk management programs in primary care for high risk patients. Results of long term...
-
Improving cardiovascular health in patients with an abdominal aortic aneurysm: development of the cardiovascular risk reduction in patients with aneurysms (CRISP) behaviour change intervention
BackgroundAbdominal aortic aneurysm (AAA) is an important cardiovascular health problem. Ultrasound screening is proven to reduce AAA mortality and...
-
Polypill and Combination Therapy: Blood Pressure and Cardiovascular Risk Reduction
Purpose of ReviewThe number of medications prescribed to patients has been progressively increasing, primarily driven by cardioprotective...
-
Precision Nutrition and Cardiovascular Disease Risk Reduction: the Promise of High-Density Lipoproteins
Purpose of ReviewEmerging evidence supports the promise of precision nutritional approaches for cardiovascular disease (CVD) prevention. Here, we...
-
The menopausal transition period and cardiovascular risk
The menopausal transition period spans, on average, 2–8 years before the final menstrual period and is associated with an increase in clinical and...
-
Increased cardiovascular risk in patients with chronic kidney disease
Cardiovascular disease (CVD) is highly prevalent in patients suffering from chronic kidney disease (CKD). The risk of patients with CKD develo**...
-
Cardiovascular Risk Estimation and Stratification Among Individuals with Hypercholesterolemia
Purpose of the ReviewThis review aims to assess the variability in considering hypercholesterolemia for cardiovascular risk stratification in the...
-
Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by an increased risk of cardiovascular events, due to the complex interplay...
-
Does Systemic Anti-Psoriatic Treatment Impact the Risk of Cardiovascular Disease? A Review Over Cardiovascular Imaging Studies
Psoriasis is an immune-mediated inflammatory disease associated with an increased risk of cardiovascular disease (CVD). The risk of CVD increases...
-
Transgender healthcare: metabolic outcomes and cardiovascular risk
Transgender identity is often associated with gender dysphoria and minority stress. Gender-affirming hormone treatment (GAHT) includes masculinising...
-
Impact of Lipoprotein(a) Levels on Cardiovascular Risk Estimation
IntroductionA new cardiovascular risk (CVR) calculator that incorporates Lipoprotein(a) [Lp(a)] levels has recently been designed.
Aims ...
-
Social Risk Factors That Increase Cardiovascular and Breast Cancer Risk
Purpose of ReviewCardiovascular disease (CVD) and breast cancer (BC) are significant causes of mortality globally, imposing a substantial health...
-
Potential Predictors of Cardiovascular Risk Improvement in Patients with Hidradenitis Suppurativa Treated with Adalimumab: A Pivotal Study of Factors Associated with Carotid Intima–Media Thickness Reduction
IntroductionHidradenitis suppurativa (HS) has been linked to higher cardiovascular risk (CVR) due to its inflammatory burden. There is little...
-
Bibliometric analysis of residual cardiovascular risk: trends and frontiers
BackgroundThe presence of residual cardiovascular risk is an important cause of cardiovascular events. Despite the significant advances in our...
-
Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy
Purpose of ReviewChronic kidney disease (CKD) is associated with a significantly increased risk of cardiovascular disease (CVD). This review...
